CORE--RECOMBINANT DNA
$209,639P01FY2000GMNIH
University Of Iowa, Iowa City IA
Investigators
Linked publications & trials
Paper 17253771Paper 16503637Paper 16481317Paper 16155005Paper 15835899Paper 15751957Paper 15504030Paper 15479102Paper 15385676Paper 15361521Paper 15234986Paper 15196028Paper 15196027Paper 15096052Paper 14995168Paper 14705937Paper 14688246Paper 12962322Paper 12939139Paper 12914082Paper 12846576Paper 12741834Paper 12736253Paper 12488314Paper 12071726Paper 12070336Paper 11976324Paper 11779242Paper 11772037Paper 11604545Paper 11591155Paper 11514675Paper 11412112Paper 11329273Paper 11112521Paper 10737937Paper 10716987
Abstract
This core will create site-directed mutations of the alpha and beta globin subunits of human hemoglobin and will over-express these modified globins in E. coli using protocols that were optimized during last funding period of this Program Project Grant. In addition, strategies will be devised for producing globin subunits in which only a single type of amino acid is labeled with 13C. The frozen E. coli cell pasted produced in this core will be shipped to the Hemoglobin Assembly Core where the mutant hemoglobin tetramers will be assembled and purified.
View original record on NIH RePORTER →